webinar register page

Webinar banner
Genprex Presentation October 14th
Genprex (GNPX) is a clinical stage gene therapy company. It is engaged in developing a new approach to treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Market Cap 133.59m

Presentation and Meetings on October 14th, 2020

Oct 14, 2020 08:00 AM in Pacific Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Marissa Zumbo.